Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CBR1 anticorps (AA 176-268)

CBR1 Reactivité: Humain WB, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7146741
  • Antigène Voir toutes CBR1 Anticorps
    CBR1 (Carbonyl Reductase 1 (CBR1))
    Épitope
    • 15
    • 9
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 176-268
    Reactivité
    • 47
    • 34
    • 12
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 49
    • 14
    • 1
    Lapin
    Clonalité
    • 51
    • 12
    Polyclonal
    Conjugué
    • 39
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp CBR1 est non-conjugé
    Application
    • 52
    • 20
    • 14
    • 13
    • 13
    • 10
    • 9
    • 8
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    Western Blotting (WB), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain, Souris
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Carbonyl reductase [NADPH] 1 protein (176-268AA)
    Isotype
    IgG
    Top Product
    Discover our top product CBR1 Anticorps primaire
  • Indications d'application
    Recommended dilution: WB:1:500-1:5000, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    CBR1 (Carbonyl Reductase 1 (CBR1))
    Autre désignation
    CBR1 (CBR1 Produits)
    Synonymes
    anticorps LOC100222525, anticorps MGC131152, anticorps CBR, anticorps SDR21C1, anticorps hCBR1, anticorps 9-KPR, anticorps AW261796, anticorps CR, anticorps Cbr, anticorps carbonyl reductase 1, anticorps carbonyl reductase [NADPH] 1, anticorps carbonyl reductase 1 S homeolog, anticorps carbonyl reductase, anticorps cbr1, anticorps CBR1, anticorps LOC100222525, anticorps cbr1.S, anticorps Smp_033530.3, anticorps LOC610164, anticorps Cbr1
    Sujet

    Background: NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione.

    Aliases: 15 hydroxyprostaglandin dehydrogenase [NADP+] antibody, 15-hydroxyprostaglandin dehydrogenase [NADP+] antibody, Carbonyl reductase [NADPH] 1 antibody, Carbonyl Reductase 1 antibody, CBR 1 antibody, CBR1 antibody, CBR1_HUMAN antibody, CRN antibody, NADPH dependent carbonyl reductase 1 antibody, NADPH-dependent carbonyl reductase 1 antibody, Prostaglandin 9 ketoreductase antibody, Prostaglandin 9-ketoreductase antibody, Prostaglandin E(2) 9 reductase antibody, Prostaglandin-E(2) 9-reductase antibody, SDR21C1 antibody

    UniProt
    P16152
Vous êtes ici:
Support technique